← Back to feedRead original →
VERIFIEDET Markets·positive
Aurobindo Pharma gains over 3% as subsidiary launches generic Advair Diskus in US; stock up 41% YTD
AI Summary
- ·Aurobindo Pharma's subsidiary Lannett Company launched a generic Advair Diskus in the US.
- ·The product is available in two strengths and is the first commercialised product from Aurobindo's inhalation pipeline.
- ·Aurobindo Pharma's stock has risen 41.16% year-to-date.